Free Trial

Senseonics Q4 2023 Earnings Report

Senseonics logo
$0.85 -0.03 (-3.10%)
As of 01/17/2025 04:00 PM Eastern

Senseonics EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.04
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Senseonics Revenue Results

Actual Revenue
$8.00 million
Expected Revenue
$7.62 million
Beat/Miss
Beat by +$380.00 thousand
YoY Revenue Growth
N/A

Senseonics Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Senseonics Earnings Headlines

Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
See More Senseonics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Senseonics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Senseonics and other key companies, straight to your email.

About Senseonics

Senseonics (NYSE:SENS), a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

View Senseonics Profile

More Earnings Resources from MarketBeat